Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1997-08-05
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548161, A61K 31425, C07D27768
Patent
active
056543239
ABSTRACT:
A compound of formula (I): ##STR1## in which X, n, B and Y are as defined in the description. useful as cytokine inhibitors.
REFERENCES:
patent: 2645640 (1953-07-01), Charpentier
patent: 3177211 (1965-04-01), Zenitz
patent: 3313810 (1967-04-01), Nakanishi
patent: 3637679 (1972-01-01), Lovell
patent: 3966930 (1976-06-01), Buus
patent: 4049419 (1977-09-01), D'Amico
patent: 4548934 (1985-10-01), Fengler
Chemical Abstracts 51, 12101 (b), (c) 1957 (Fujii).
Fujii Chem Ab, 51, 12101 f (1957) Not Applied.
Bonnet Jacqueline
Brion Jean-Daniel
Chollet Anne-Marie
De Montarby Lucy
Demuynck Luc
Adir et Compagnie
Gerstl Robert
LandOfFree
Heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075148